Amyloid-Beta
-
healthMass General Brigham Study Links Daily Walking to Delayed Alzheimer’s Onset
New research from Mass General Brigham indicates walking 5,000 to 7,500 steps daily may delay cognitive decline by seven years in adults with elevated amyloid-beta levels.
-
healthSleeping Pill Shows Promise in Reducing Alzheimer's Proteins in Small Study
A brief trial found the insomnia drug suvorexant lowered amyloid-beta and tau in healthy adults, but experts urge caution.
-
healthMajor Cochrane Review Questions Effectiveness of Alzheimer's Drugs
A Cochrane review finds amyloid-targeting drugs offer little benefit, sparking debate among experts and drugmakers.
-
healthWeight-Loss Drugs Show Potential in Reducing Alzheimer's Protein Buildup
A major review suggests popular GLP-1 weight-loss drugs may help limit the molecular hallmarks of Alzheimer's disease, reducing amyloid-beta and tau proteins in preclinical studies.
-
healthScientists Identify Brain's 'Molecular Switch' Protecting Against Alzheimer's Decline
New research reveals a protein, chromogranin A, may be key to cognitive resilience in Alzheimer's, offering potential therapeutic targets.
-
healthNew Blood Test Shows Promise for Early Alzheimer's Prediction
Groundbreaking research indicates a blood biomarker, pTau217, could identify Alzheimer's risk years before symptoms manifest, potentially revolutionizing early detection and intervention.